Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Organic Chemistry|October 10, 2015
Cobalt-Catalyzed Decarboxylative 2-Benzoylation of Oxazoles and Thiazoles with α-Oxocarboxylic AcidsKe Yang, Xinyong Chen, Yuqi Wang, et al.
ACS Omega|October 14, 2024
Synthesis and Evaluation of Thiazolyl-indole-2-carboxamide Derivatives as Potent Multitarget Anticancer AgentsNjood M Saadan, Wahid U Ahmed, Adnan A Kadi, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
New ultra-short acting hypnotic: synthesis, biological evaluation, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]diazepin-3-carboxylate (HIE-124)Hussein I El-Subbagh, Hassan A El-Kashef, Adnan A Kadi, et al.
Drug Design, Development and Therapy|August 30, 2017
Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profilingHatem A Abdel-Aziz, Wagdy M Eldehna, Adam B Keeton, et al.
Archives of Pharmacal Research|February 5, 2018
Linear diarylheptanoids as potential anticancer therapeutics: synthesis, biological evaluation, and structure-activity relationship studiesA F M Motiur Rahman, Yang Lu, Hwa-Jong Lee, et al.
Archiv Der Pharmazie|January 25, 2008
Synthesis, ultra-short acting hypnotic activity, and metabolic profile of ethyl 8-oxo-5,6,7,8-tetrahydro-thiazolo[3,2-a] [1,3]diazepin-3-carboxylate (HIE-124)Adnan A Kadi, Hassan A El-Kashef, Alaa A-M Abdel-Aziz, et al.
Chemical Research in Toxicology|May 7, 2020
EGFR Inhibitor Gefitinib Induces Cardiotoxicity through the Modulation of Cardiac PTEN/Akt/FoxO3a Pathway and Reactive Metabolites Formation: In Vivo and in Vitro Rat StudiesAli Alhoshani, Fawaz E Alanazi, Moureq R Alotaibi, et al.
Chemistry & Biodiversity|April 30, 2025
Potent Anti-Cancer Activity of Benzo[d]Thiazole-Isatin Conjugates: Induces S Phase Arrest and Cell Necrosis in A549 and HepG2 CellsBashayer A Saeed, Wahid U Ahmed, Aljawharah A Alshekh, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 15, 2007
Bioequivalence evaluation of 320 mg gemifloxacin tablets in healthy volunteersA M Al-Mohizea, A A Kadi, A M Al-Bekairi, et al.
Profiles of Drug Substances, Excipients, and Related Methodology|February 29, 2024
Ponatinib: A comprehensive drug profileMohamed W Attwa, Hamad M Alkahtani, Adel S El-Azab, et al.
Pageof 15